Company / Current Assets
Vera Therapeutics, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$728.9M
FY2025
5-year range
$82.5M / $728.9M
FY2021-FY2025
Trend
+11.9%
vs FY2024
Sector context
#76 of 213
Health Care
What the data says
At $729M, Vera Therapeutics, Inc.'s current assets ranks #76 of 213 in the Health Care sector. Current Assets has increased for 5 consecutive years, from $54M in FY2020 to $729M in FY2025.
Based on SEC 10-K filings.
$729M in FY2025 with a 5-year CAGR of +68.1%.
Improved from $172M to $729M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +79.7%
- 5-Year CAGR
- +68.1%
- 10-Year CAGR
- -
Sector benchmark
#76 of 213 in Health CareTop 36% of 213This company $728.9M Sector average $2.5B
▼
-71.1% below sector average
Key checks
Key Insights
- Vera Therapeutics, Inc.'s current assets has grown for 5 consecutive years.
- 5-year CAGR of +68.1%, indicating consistent growth.
- In FY2025, current assets increased 11.9% year-over-year.
- Ranks #76 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $728.9M | +11.9% |
| FY2024 | $651.2M | +278.6% |
| FY2023 | $172.0M | +36.9% |
| FY2022 | $125.7M | +52.3% |
| FY2021 | $82.5M | +52.1% |
| FY2020 | $54.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026